FDA recall record

EYLEA recall — FDA D-0479-2024

Lack of Assurance of Sterility: Complaints of syringe breakage

Class IIclassification
D-0479-2024official record ID
May 8, 2024report date

Recall record at a glance

Official recordD-0479-2024
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmRegeneron Pharmaceuticals Inc.
Report dateMay 8, 2024
Recall initiation dateApr 23, 2024
Quantity251,504 syringes
LocationTarrytown, NY, United States

Official product description

EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01

Why the product was recalled

Lack of Assurance of Sterility: Complaints of syringe breakage

Distribution information

USA Nationwide

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugJun 5, 2024

EYLEA recall — FDA D-0531-2024

Lack of Assurance of Sterility: Complaints of syringe breakage

Class IIFDA: TerminatedRegeneron Pharmaceuticals Inc.